Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
efalex (1 trial)
npi-001 (1 trial)
raav2.rep1 (1 trial)
valproic acid (depakene) (1 trial)
brinzolamide (azopt) (1 trial)
dorzolamide (trusopt) (1 trial)
vitamin a (1 trial)
Choroideremia (Phase 2)
Genetic Diseases, Inborn (Phase 2)
Genetic Diseases, X-Linked (Phase 2)
Retinitis (Phase 2)
Retinitis Pigmentosa (Phase 2)
Syndrome (Phase 2)
Usher Syndromes (Phase 2)
Trials (6 total)
Trial APIs (7 total)